TABLE I.
FasL Effects on Anti-apoptotic Gene ExpressionϮ
Anti-apoptosis gene | Fold up- or down-regulation (FasL NPC/control NPC) |
---|---|
Akt1 | 1.07 |
Api5 | 1.05 |
Ataf | −1.19 |
Bag1 | −1.15 |
Bag3 | −1 |
Bcl2 | 1.27 |
Bcl2l1 | −1.15 |
Bcl2l2 | −1.08 |
Birc1a | 1.15 |
Birc1b | 1.07 |
Birc2 | 1.07 |
Birc3 | 7.19** |
Birc4 | 1.14 |
Birc5 | 1.03 |
Bnip3 | 1.05 |
Casp2 | −1.25 |
Cflar | 1.49 |
Dad1 | 2.06* |
Tsc22d3 | 1.01 |
Hells | 1.52 |
Il01 | 1.69 |
Lhx4 | −1.29 |
Mcl1 | −1.02 |
Nfkb1 | 1.02 |
Nme5 | 1.09 |
Pax7 | 1.21 |
Pim2 | 1.19 |
Polb | 1.02 |
Prdx2 | −1.15 |
Rnf7 | −1.02 |
Sphk2 | 1.01 |
Tnf | −1.03 |
Cd40lg | 1.08 |
Zc3hc | 1.12 |
Results from mouse apoptosis gene array analysis. RNA was extracted from NPC control and FasL (200 ng/ml)-treated cells grown in minimal medium for 48 hr. Among all the antiapoptotic genes tested, Birc3 was the only one that showed a significant change in mRNA expression with FasL treatment. -Fold differences and P values obtained from averaging three separate arrays. Positive numbers indicate up-regulation; negative numbers indicate down-regulation. -Fold difference obtained with the equation (2−ΔCt FasL)/(2−ΔCt control)
P < 0.05
P < 0.00001